ATE175415T1 - Neue n-aralkyl- und n- heteroaralkylaminoalkanphosphinsäuren - Google Patents

Neue n-aralkyl- und n- heteroaralkylaminoalkanphosphinsäuren

Info

Publication number
ATE175415T1
ATE175415T1 AT93810316T AT93810316T ATE175415T1 AT E175415 T1 ATE175415 T1 AT E175415T1 AT 93810316 T AT93810316 T AT 93810316T AT 93810316 T AT93810316 T AT 93810316T AT E175415 T1 ATE175415 T1 AT E175415T1
Authority
AT
Austria
Prior art keywords
aralkyl
acids
heteroaralkylaminoalkanophosphic
new
nootropic
Prior art date
Application number
AT93810316T
Other languages
German (de)
English (en)
Inventor
Stuart John Dr Mickel
Wolfgang Dr Froestl
Pascal Dr Furet
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE175415T1 publication Critical patent/ATE175415T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings
    • C07F9/65306—Five-membered rings containing two nitrogen atoms
    • C07F9/65318—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
    • C07F9/6518—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07F9/653—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
  • Meat, Egg Or Seafood Products (AREA)
  • Alcoholic Beverages (AREA)
  • Inorganic Compounds Of Heavy Metals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT93810316T 1992-05-08 1993-04-29 Neue n-aralkyl- und n- heteroaralkylaminoalkanphosphinsäuren ATE175415T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH148092 1992-05-08

Publications (1)

Publication Number Publication Date
ATE175415T1 true ATE175415T1 (de) 1999-01-15

Family

ID=4211459

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93810316T ATE175415T1 (de) 1992-05-08 1993-04-29 Neue n-aralkyl- und n- heteroaralkylaminoalkanphosphinsäuren

Country Status (18)

Country Link
US (2) US5332729A (enExample)
EP (1) EP0569333B1 (enExample)
JP (1) JP3243056B2 (enExample)
KR (1) KR940005649A (enExample)
AT (1) ATE175415T1 (enExample)
AU (1) AU662404B2 (enExample)
CA (1) CA2095708C (enExample)
DE (1) DE59309265D1 (enExample)
ES (1) ES2128409T3 (enExample)
FI (1) FI932028L (enExample)
GR (1) GR3029899T3 (enExample)
HU (1) HUT64079A (enExample)
IL (1) IL105628A0 (enExample)
NO (1) NO931675L (enExample)
NZ (1) NZ247561A (enExample)
PH (1) PH30222A (enExample)
TW (1) TW224966B (enExample)
ZA (1) ZA933206B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5457095A (en) * 1984-10-12 1995-10-10 Ciba-Geigy Corporation Substituted propane-phosponous acid compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
WO1997011953A1 (en) * 1995-09-28 1997-04-03 Novartis Ag Novel hydroxylated and alkoxylated n- and/or p-aralkylphosphinic acid derivatives
CA2254862A1 (en) * 1996-05-30 1997-12-11 Novartis Ag Metabotropic gaba[b] receptors, receptor-specific ligands and their uses
US7119189B2 (en) 1997-03-19 2006-10-10 Novartis Ag Metabotropic GABA [B] receptors, receptor-specific ligands and their uses
GB9906882D0 (en) * 1999-03-25 1999-05-19 Novartis Ag Organic compounds
US7319095B2 (en) * 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
SE9904508D0 (sv) * 1999-12-09 1999-12-09 Astra Ab New compounds
JP4709488B2 (ja) * 2002-01-18 2011-06-22 メルク・シャープ・エンド・ドーム・コーポレイション Ｅｄｇ受容体作動薬としてのＮ−（ベンジル）アミノアルキルカルボン酸化合物、ホスフィン酸化合物、ホスホン酸化合物およびテトラゾール類
AR045794A1 (es) * 2003-09-23 2005-11-16 Aventis Pharma Inc Procedimiento para preparar derivados de acido 3- amino-2- hidroxipropilfosfinico
GB0327186D0 (en) * 2003-11-21 2003-12-24 Novartis Ag Organic compounds
CA2566204A1 (en) * 2004-05-14 2005-12-01 The Johns Hopkins University Method for improving cognitive function by co-administration of a gabab receptor antagonist and an acetylcholinesterase inhibitor
US7566738B2 (en) * 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
US7494985B2 (en) * 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7585996B2 (en) * 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3493639A (en) * 1965-10-27 1970-02-03 Shell Oil Co Process for producing pentavalent phosphorus derivatives
JPS4714129Y1 (enExample) * 1969-06-11 1972-05-22
DE2032712C3 (de) * 1970-07-02 1978-10-19 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von w-Amino-alkanphosphonsäure bzw.- phosphinsäurederivaten
DE2440239A1 (de) * 1974-08-22 1976-03-04 Hoechst Ag Innere ammoniumsalze von phosphinsaeuren
JPS5463024A (en) * 1977-10-27 1979-05-21 Fujisawa Pharmaceut Co Ltd 3-(n-formyl-n-hydroxyamino)-2(r)-hydroxypropyl-phosphonic acid, its preparation, and its use
EP0093081B1 (de) * 1982-04-23 1986-03-19 Ciba-Geigy Ag Herbizide und pflanzenwuchsregulierende Mittel
US4536355A (en) * 1982-10-08 1985-08-20 Zoecon Corporation Phenoxyphenylaminoalkylphosphinates useful in weed control
GB8425872D0 (en) * 1984-10-12 1984-11-21 Ciba Geigy Ag Chemical compounds
FR2572078B1 (fr) * 1984-10-24 1988-07-15 Inst Francais Du Petrole Phosphobetaines neutres, leur preparation et leur application a la recuperation assistee du petrole
USD302521S (en) 1986-03-13 1989-08-01 Grinde James E Dual compartment container with measurement indicator
US5190933A (en) * 1987-12-04 1993-03-02 Ciba-Geigy Corporation Substituted propane-phosphinic acid compounds
GB8728483D0 (en) * 1987-12-04 1988-01-13 Ciba Geigy Ag Chemical compounds
GB8820266D0 (en) * 1988-08-26 1988-09-28 Smith Kline French Lab Compounds
US5212164A (en) * 1988-08-29 1993-05-18 E. R. Squibb & Sons, Inc. Phosphorus-containing squalene synthetase inhibitors
US5190934A (en) * 1989-06-03 1993-03-02 Ciba-Geigy Corporation P-subsituted propane-phosphinic acid compounds
IL114631A (en) * 1990-06-22 1998-12-06 Novartis Ag Anti-epileptic compositions containing gabab- antagonistic compounds
EP0543780A3 (en) * 1991-11-21 1993-09-01 Ciba-Geigy Ag Novel aminoalkanephosphinic acids and their salts
GB9125615D0 (en) * 1991-12-02 1992-01-29 Wyeth John & Brother Ltd Amines

Also Published As

Publication number Publication date
DE59309265D1 (de) 1999-02-18
EP0569333B1 (de) 1999-01-07
EP0569333A3 (enExample) 1994-04-06
AU662404B2 (en) 1995-08-31
FI932028A7 (fi) 1993-11-09
CA2095708A1 (en) 1993-11-09
PH30222A (en) 1997-02-05
JP3243056B2 (ja) 2002-01-07
ZA933206B (en) 1993-11-08
IL105628A0 (en) 1993-09-22
HU9301332D0 (en) 1993-09-28
GR3029899T3 (en) 1999-07-30
HUT64079A (en) 1993-11-29
ES2128409T3 (es) 1999-05-16
FI932028A0 (fi) 1993-05-05
CA2095708C (en) 2005-12-06
TW224966B (enExample) 1994-06-11
AU3711293A (en) 1993-11-11
KR940005649A (ko) 1994-03-22
JPH0632793A (ja) 1994-02-08
US5332729A (en) 1994-07-26
US5424441A (en) 1995-06-13
NO931675D0 (no) 1993-05-07
FI932028L (fi) 1993-11-09
EP0569333A2 (de) 1993-11-10
NZ247561A (en) 1995-07-26
NO931675L (no) 1993-11-09

Similar Documents

Publication Publication Date Title
ATE175415T1 (de) Neue n-aralkyl- und n- heteroaralkylaminoalkanphosphinsäuren
ATE129500T1 (de) Neuartige antiepileptika.
DK300281A (da) N-hydroxyalkylerede dicarboxylsyrebis-(3,5-dicarbamoyl-1-2,4,6-trijodanilider fremgangsmaade til fremstilling heraf samt roentgenkontrastmidler med indhold heraf
DK0855401T3 (da) Kontrastsammensætninger til kernemagnetisk resonans
ATE155140T1 (de) 3-deoxyoligosacchariden, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
AU5670690A (en) Lysolecithin derivatives for treating autoimmune diseases
IE801441L (en) Triiod0isophthalic acids, x-ray contrast agents
DK288686A (da) Farmaceutiske praeparater
DE69203551D1 (de) Biologisch abbaubarer Copolyester von 4-Hydroxyprolin und diesen enthaltende pharmazeutische Zusammensetzung.
TW281673B (enExample)
TW273555B (enExample)
HU902612D0 (en) Process for the preparation of 4-phenylmethyl-1h-indole derivatives
AU555533B2 (en) Substituted thiazolidinyl esters of mineral acids
ES2067717T3 (es) Compuestos de acidos propano-fosfinicos p-sustituidos.
AU3873189A (en) 5-substituted uridine derivatives and intermediates for their preparation
ATE89551T1 (de) Verfahren zur herstellung von optisch aktiven acyloxyazetidinonen.
GR3002075T3 (en) 4-hydroxy-4-(substituted alkenyl)-cyclohexane carboxylic acid
EP0394840A3 (de) 4- Hydroperoxi-2-alkensäuren und deren Ester
GR3004354T3 (enExample)
ES2059650T3 (es) Compuesto de cristal liquido esmectico quiral ferroelectrico y dispositivo de cristal liquido que utiliza el mismo.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee